1. Eligibility certified by Ministry of Economy and Energy!
2. 20% subsidisation of venture capital by INVEST support measure
News
Birth weight and head circumference predict IQ and motor performance at 4 years of age
Annual general meeting in BrainRepair AB (publ) on 27 June 2023
Voting Sheet PDF 27KB
Notice of AGM 2023 (EN) PDF 22KB
Notice of AGM 2023 (SW) PDF 22KB
Proxy form AGM (EN) PDF 65KB
Proxy form AGM (SW) PDF 13KB
Annual Report 2022
Cerebral palsy – brain repair with stem cells
Association of weight-length ratio at birth with psychomotor trajectories among preschool-aged children
Brain repair with stem cells – Prof. A. Jensen
Foundation for the Child with Handicap, University Hospital Bonn, May 21, 2022
Perinatal Brain damage – Prevention and therapy, Chairman: Prof. A. Jensen
30. Kongress der Deutschen Gesellschaft für Perinatale Medizin, 25. November 2021
Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG
Investitions-Durchbruch beim Start-up BrainRepair UG – Stammzellenbehandlung für Neugeborene / Dr. Metin Colpan, Gründer von Qiagen N.V. (Nasdaq N.Y.) erwirbt 5% von BrainRepair.
https://pressemitteilungen.sueddeutsche.de/brainrepair-ug-4925644
MICHAEL SCHUMACHER IS NOW ‘CONSCIOUS’ AFTER STEM-CELL TREATMENT
- his former F1 boss Jean Todt visits him for 45 minutes
Nachricht an Herrn Michael Schumacher:
Lieber Herr Schumacher,
alle guten Wünsche der BrainRepair UG begleiten Sie auf dem Weg zu Ihrer Genesung. Wir haben Kinder nach Schädigungen des Gehirns mit Stammzellen aus dem eigenen Nabelschnurblut behandelt und u.a. ähnlich dramatische Erfolge mit Wiedererlangung des Bewußtseins als Beginn einer nachhaltigen Erholung gesehen. Wir freuen uns mit Ihnen und Ihrer Familie und wünschen weiter gute Besserung.
Ihr Arne Jensen | CEO
REGULATORY BREAKTHROUGH FOR BRAINREPAIR UG START-UP – STEM CELL TREATMENT FOR NEWBORNS
Regulatorischer Durchbruch beim Start-up BrainRepair UG – Stammzellenbehandlung für Neugeborene kommt
Charity for BrainRepair – 4th Half Marathon of the CEO after 70 km of Training
on 08/28/2020. Donation … EUR 10 for every 91.2 kilometers run for STOP-CP for Children! e.V.
BrainRepair UG in ‘GLOBAL ENCEPHALOPATHY DRUG PIPELINE TRENDS 2019’
along with Celgene Corp, Takeda Pharmaceutical Co Ltd and 10 other companies.
Nobel Prize 2019 – Antecendents to HIF discovery
The relation between O2 delivery and tissue oxygen consumption
Congratulations – Our partner Genepath Laboratories is expanding
globally!
Associated Press: RUB-Medics: UNIQUE INDEX AT BIRTH PREDICTS DISABILITY AT 4 YEARS OF AGE
- solid basis for early active rehabilitation and cell-based therapies
BrainRepair UG proudly announces eligibility for INVEST support measure:
BrainRepair UG welcomes two new investors:
1. Family Office A & C, Germany
and
2. US Entrepreneur, scientist, and founder (EP Technologies Inc. / Boston Scientific, Inc.) Michael R. Franz, M.D., Ph.D., Professor of Medicine and Pharmacology, Georgetown University, Dept. Cardiology, Washington D.C., USA
BrainRepair UG welcomes a new strategic partner:
1. Genepath Laboratories, Sydney, Australia – Next generation sequencing
Accreditations: NATA, RCPA